Oncology Institute Stock Probability of Future Stock Price Finishing Under 0.15
| TOI Stock | USD 0.15 0.01 6.25% |
Oncology |
Oncology Institute Target Price Odds to finish below 0.15
The tendency of Oncology Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 0.15 | 90 days | 0.15 | near 1 |
Based on a normal probability distribution, the odds of Oncology Institute to move below current price in 90 days from now is near 1 (This Oncology Institute probability density function shows the probability of Oncology Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 2.19 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Oncology Institute will likely underperform. Additionally Oncology Institute has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Oncology Institute Price Density |
| Price |
Predictive Modules for Oncology Institute
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oncology Institute. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Oncology Institute Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Oncology Institute is not an exception. The market had few large corrections towards the Oncology Institute's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Oncology Institute, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Oncology Institute within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.28 | |
β | Beta against Dow Jones | 2.19 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.16 |
Oncology Institute Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oncology Institute for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oncology Institute can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Oncology Institute generated a negative expected return over the last 90 days | |
| Oncology Institute has high historical volatility and very poor performance | |
| Oncology Institute has some characteristics of a very speculative penny stock | |
| Oncology Institute has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 324.24 M. Reported Net Loss for the year was (83.07 M) with profit before taxes, overhead, and interest of 52.09 M. | |
| Oncology Institute has about 64.21 M in cash with (36.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 1026 shares by Podnos Yale of Oncology Institute at 0.136 subject to Rule 16b-3 |
Oncology Institute Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oncology Stock often depends not only on the future outlook of the current and potential Oncology Institute's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oncology Institute's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 73.7 M | |
| Cash And Short Term Investments | 82.9 M |
Oncology Institute Technical Analysis
Oncology Institute's future price can be derived by breaking down and analyzing its technical indicators over time. Oncology Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oncology Institute. In general, you should focus on analyzing Oncology Stock price patterns and their correlations with different microeconomic environments and drivers.
Oncology Institute Predictive Forecast Models
Oncology Institute's time-series forecasting models is one of many Oncology Institute's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Oncology Institute's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Oncology Institute
Checking the ongoing alerts about Oncology Institute for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Oncology Institute help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Oncology Institute generated a negative expected return over the last 90 days | |
| Oncology Institute has high historical volatility and very poor performance | |
| Oncology Institute has some characteristics of a very speculative penny stock | |
| Oncology Institute has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 324.24 M. Reported Net Loss for the year was (83.07 M) with profit before taxes, overhead, and interest of 52.09 M. | |
| Oncology Institute has about 64.21 M in cash with (36.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 1026 shares by Podnos Yale of Oncology Institute at 0.136 subject to Rule 16b-3 |
Check out Oncology Institute Backtesting, Oncology Institute Valuation, Oncology Institute Correlation, Oncology Institute Hype Analysis, Oncology Institute Volatility, Oncology Institute History as well as Oncology Institute Performance. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share 4.873 | Quarterly Revenue Growth 0.229 | Return On Assets (0.19) | Return On Equity (1.26) |
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.